REGISTRAT-MAPI and Trianz Solutions are pleased to announce a further strengthening of their relationship via the release of Acceliant V6.1. REGISTRAT-MAPI has utilized Acceliant since 2007 for many of their Late Phase clinical studies. Acceliant V6.1, released earlier this year incorporates a number of new functional enhancements and UI architectures.
Acceliant 6.1 is a full life cycle e-Clinical Trials EDC platform comprised of Clinical Data Management, regulatory compliant Document Management, core Trial Management facilitating collaboration and site management, and business intelligence capabilities. Acceliant features a proprietary Accelerated Trial Builder, which allows non-technical users to accomplish end-to-end configuration and build of a trial without the need for any programming. The Accelerated Trial Builder enables users to define data-fields, edit checks, code lists, complete CRF layouts, validate the build and then deploy the trial with a single click.
Based on an integrated design and architecture, all Acceliant modules and features have been designed and built as a single native platform. Version 6.1 includes technology-driven usability features that are beneficial when working with large trials involving thousands of sites and patients; several design improvements for efficiently handling large scale data sets; powerful capabilities for import/export of large data sets; and rapid edit and validation of test data. These enhancements provide benefits for all trial phases.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.